CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,969,000 | -52.3% | 183,151 | -32.9% | 0.18% | -61.3% |
| Q4 2018 | $4,125,000 | -4.4% | 273,151 | +17.2% | 0.46% | -6.1% |
| Q3 2018 | $4,313,000 | +126.9% | 233,151 | +180.4% | 0.50% | +88.9% |
| Q2 2018 | $1,901,000 | -62.9% | 83,142 | -53.8% | 0.26% | -66.3% |
| Q1 2018 | $5,121,000 | +51.6% | 180,000 | +12.5% | 0.78% | +96.2% |
| Q4 2017 | $3,378,000 | -11.5% | 160,000 | -23.8% | 0.40% | -27.2% |
| Q3 2017 | $3,816,000 | +23.1% | 210,000 | +5.0% | 0.54% | +3.2% |
| Q2 2017 | $3,100,000 | +19.6% | 200,000 | +33.3% | 0.53% | +3.9% |
| Q1 2017 | $2,591,000 | – | 150,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |